Miriam Longo

1.8k total citations
48 papers, 1.2k citations indexed

About

Miriam Longo is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Miriam Longo has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 16 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in Miriam Longo's work include Liver Disease Diagnosis and Treatment (35 papers), Diet, Metabolism, and Disease (11 papers) and Endoplasmic Reticulum Stress and Disease (10 papers). Miriam Longo is often cited by papers focused on Liver Disease Diagnosis and Treatment (35 papers), Diet, Metabolism, and Disease (11 papers) and Endoplasmic Reticulum Stress and Disease (10 papers). Miriam Longo collaborates with scholars based in Italy, Sweden and Finland. Miriam Longo's co-authors include Paola Dongiovanni, Marica Meroni, Anna Ludovica Fracanzani, Erika Paolini, Silvia Fargion, Raffaela Rametta, Chiara Macchi, Luca Valenti, Massimiliano Ruscica and Luca Miele and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Lipid Research.

In The Last Decade

Miriam Longo

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Miriam Longo

Since Specialization

Citations

This map shows the geographic impact of Miriam Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Longo more than expected).

Fields of papers citing papers by Miriam Longo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Longo. The network helps show where Miriam Longo may publish in the future.

Co-authorship network of co-authors of Miriam Longo

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Longo. A scholar is included among the top collaborators of Miriam Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Longo. Miriam Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of semaglutide on limb events: a meta-analysis of randomized controlled trials 2026 ·European Journal of Preventive Cardiology ·(unknown), (unknown), Miriam Longo, Alessandra Antonucci, Maria Ida Maiorino, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Smart insulin pen after pancreatectomy: a successful strategy for managing type 3c diabetes 2025 ·Acta Diabetologica ·Miriam Longo, Michela Petrizzo, Paola Caruso, Maria Ida Maiorino, (unknown)	0
3	Unilateral Graves' disease: a case report with concomitant thyroid cancer and systematic review of literature 2025 ·Minerva Surgery ·Lorenzo Scappaticcio, Paola Caruso, Miriam Longo, (unknown), Paolo Cirillo, (unknown), (unknown), Vanda Amoresano Paglionico, (unknown), Maria Ida Maiorino, Katherine Esposito, Giuseppe Bellastella	0
4	A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach 2024 ·Journal of Advanced Research ·Marica Meroni, Miriam Longo, Erika Paolini, Paola Dongiovanni	15
5	DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application 2024 ·International Journal of Molecular Sciences ·Miriam Longo, Erika Paolini, (unknown), (unknown), Marica Meroni, Paola Dongiovanni	4
6	Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin 2024 ·Frontiers in Endocrinology ·Marica Meroni, Miriam Longo, Paola Dongiovanni	3
7	Circulating mitochondrial bioenergetic profile reflects the hepatic one and represents a non-invasive biomarker of disease severity in MASLD genetically predisposed individuals 2024 ·Digestive and Liver Disease ·Erika Paolini, Miriam Longo, Marica Meroni, Paola Podini, Angelo Quattrini, Anna Ludovica Fracanzani, Paola Dongiovanni	0
8	The Alpha-Lipoic Acid Improves Glucose Metabolism and Hyperinsulinemia in Acute Intermittent Porphyria: A Nutritional Concept for the Management of Rare Disorders 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·Miriam Longo, Erika Paolini, Marica Meroni, (unknown), (unknown), (unknown), Stefano Gatti, Elena Di Pierro, Antonio Fontanellas, Paola Dongiovanni	2
9	Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria 2023 ·International Journal of Molecular Sciences ·Miriam Longo, (unknown), (unknown), José Ignacio Riezu‐Boj, Raquel Urtasun, (unknown), Ana Sampedro, María Collantes, Iván Peñuelas, María J. Moreno‐Aliaga, Matías A. Ávila, Elena Di Pierro, Miguel Barajas, Fermı́n I. Milagro, Paola Dongiovanni, Antonio Fontanellas	2
10	A novel gene signature to diagnose MASLD in metabolically unhealthy obese individuals 2023 ·Biochemical Pharmacology ·Marica Meroni, Federica Chiappori, Erika Paolini, Miriam Longo, (unknown), Ettore Mosca, (unknown), Ivan Merelli, Sara Badiali, Marco Maggioni, Alessandra Mezzelani, Luca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni	1
11	The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value 2023 ·Frontiers in Nutrition ·Erika Paolini, Miriam Longo, Marica Meroni, (unknown), Annalisa Cespiati, Rosa Lombardi, Sara Badiali, Marco Maggioni, Anna Ludovica Fracanzani, Paola Dongiovanni	6
12	The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH 2023 ·International Journal of Molecular Sciences ·Erika Paolini, Miriam Longo, Alberto Corsini, Paola Dongiovanni	6
13	α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study 2021 ·Diagnostics ·Miriam Longo, Erika Paolini, Marica Meroni, Lorena Duca, Irene Motta, Anna Ludovica Fracanzani, Elena Di Pierro, Paola Dongiovanni	9
14	Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? 2021 ·Metabolism ·Miriam Longo, Marica Meroni, Erika Paolini, Chiara Macchi, Paola Dongiovanni	74
15	TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 2021 ·Cellular and Molecular Gastroenterology and Hepatology ·Miriam Longo, Marica Meroni, Erika Paolini, (unknown), Fabrizia Carli, Francesco Fortunato, Dario Ronchi, Roberto Piciotti, Silvia Sabatini, Chiara Macchi, Anna Alisi, Luca Miele, Giorgio Soardo, Giacomo P. Comi, Luca Valenti, Massimiliano Ruscica, Anna Ludovica Fracanzani, Amalia Gastaldelli, Paola Dongiovanni	82
16	The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 2021 ·EBioMedicine ·Nadia Panera, Marica Meroni, Miriam Longo, Annalisa Crudele, Luca Valenti, Emanuele Bellacchio, Luca Miele, Valentina Doria, Erika Paolini, Marco Maggioni, Anna Ludovica Fracanzani, Anna Alisi, Paola Dongiovanni	17
17	MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 2020 ·EBioMedicine ·Marica Meroni, Miriam Longo, Anna Ludovica Fracanzani, Paola Dongiovanni	54
18	Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes 2020 ·EBioMedicine ·Marica Meroni, Paola Dongiovanni, Miriam Longo, Fabrizia Carli, Guido Baselli, Raffaela Rametta, Serena Pelusi, Sara Badiali, Marco Maggioni, Melania Gaggini, Anna Ludovica Fracanzani, Stefano Romeo, Stefano Gatti, Nicholas O. Davidson, Amalia Gastaldelli, Luca Valenti	66
19	Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Paola Dongiovanni, Marica Meroni, Salvatore Petta, Miriam Longo, Anna Alisi, Giorgio Soardo, Luca Valenti, Luca Miele, Stefania Grimaudo, Grazia Pennisi, (unknown), Dario Consonni, Silvia Fargion, Anna Ludovica Fracanzani	12
20	PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 2019 ·Journal of Lipid Research ·Paola Dongiovanni, Marica Meroni, Guido Baselli, Rosellina Margherita Mancina, Massimiliano Ruscica, Miriam Longo, Raffaela Rametta, Annalisa Cespiati, Serena Pelusi, Nicola Ferri, Valeria Ranzani, Valério Nobili, Jussi Pihlajamäki, Anna Ludovica Fracanzani, Sara Badiali, Salvatore Petta, Silvia Fargion, Stefano Romeo, Julia Kozlitina, Luca Valenti	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact